EW vs IMA · P/E 47, rev $1.39B vs rev $9.2M
Edwards Lifesciences Corp (EW) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. IMA currently screens at market cap $64.7M.
Not investment advice. Open the EW and IMA stock pages for the full models.
Not investment advice.